Biogen Inc
NASDAQ:BIIB
Wall Street
Price Targets
BIIB Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for
BIIB
is 290.45 USD
with a low forecast of 202 USD and a high forecast of 367.5 USD.
BIIB Last Price Targets
Biogen Inc
The latest public price target was made on Apr 25, 2024 by
Brian Abrahams
from
RBC Capital
,
who expects
BIIB
stock to
rise by 44%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Brian Abrahams
RBC Capital
|
317
USD
Upside 44% |
1 week ago
Apr 25, 2024
|
Biogen (BIIB) PT Lowered to $317 at RBC Capital
StreetInsider
|
Laura Chico
Wedbush
|
215
USD
Downside 3% |
1 week ago
Apr 25, 2024
|
Biogen price target raised to $215 from $213 at Wedbush
TheFly
|
|
Andrew Fein
H.C. Wainwright
|
300
USD
Upside 36% |
1 week ago
Apr 25, 2024
|
Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
StreetInsider
|
Jay Olson
Oppenheimer
|
270
USD
Upside 22% |
2 weeks ago
Apr 19, 2024
|
Biogen (BIIB) PT Lowered to $270 at Oppenheimer
StreetInsider
|
Carter Gould
Barclays
|
215
USD
Downside 3% |
1 month ago
Apr 3, 2024
|
Biogen price target lowered to $215 from $230 at Barclays
TheFly
|
|
Laura Chico
Wedbush
|
269
USD
Upside 22% |
8 months ago
Aug 7, 2023
|
What More Can Support Biogen/Sage's Zuranolone Resubmission: Analysts See Uncertain Road Ahead
Benzinga
|
Yatin Suneja
Guggenheim
|
350
USD
Upside 59% |
1 year ago
May 1, 2023
|
Biotech Is Back With Guggenheim Upgrade: What You Need To Know
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BIIB's stock price target?
Price Target
290.45
USD
According to Wall Street analysts, the average 1-year price target for
BIIB
is 290.45 USD
with a low forecast of 202 USD and a high forecast of 367.5 USD.
What is Biogen Inc's Revenue forecast?
Projected CAGR
2%
For the last 8 years the
compound annual growth rate for
Biogen Inc's revenue is
-1%.
The projected
CAGR
for the next 3 years is
2%.
What is Biogen Inc's Operating Income forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Biogen Inc's operating income is
-11%.
The projected
CAGR
for the next 3 years is
21%.
What is Biogen Inc's Net Income forecast?
Projected CAGR
37%
For the last 8 years the
compound annual growth rate for
Biogen Inc's net income is
-13%.
The projected
CAGR
for the next 3 years is
37%.
You don't have any saved screeners yet
